Outlook Therapeutics, Inc. (OTLK)
USD 1.4
(-2.78%)
USD 1.4
(-2.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 8.14 Million | 3.08 Million |
| Cost of Revenue | 44.18 Thousand | 204.69 Thousand | 262.13 Thousand | 554.06 Thousand | 23.8 Thousand | 18.5 Thousand |
| Gross Profit | -44.18 Thousand | -204.69 Thousand | -262.13 Thousand | -554.06 Thousand | 8.12 Million | 3.06 Million |
| Operating Expenses | 53.12 Million | 63.07 Million | 51.72 Million | 36.31 Million | 29.32 Million | 25.47 Million |
| Selling, General and Administrative Expenses | 26.67 Million | 20.73 Million | 13.04 Million | 8.07 Million | 5.52 Million | 6.97 Million |
| Research and Development Expenses | 26.45 Million | 42.33 Million | 38.95 Million | 26.34 Million | 23.8 Million | 18.5 Million |
| Other Expenses | - | -882.9 Thousand | - | - | - | - |
| Cost and Expenses | 53.12 Million | 63.07 Million | 51.72 Million | 36.31 Million | 32.68 Million | 28.53 Million |
| Operating Income | -53.12 Million | -63.07 Million | -51.72 Million | -36.84 Million | -36.29 Million | -25.44 Million |
| Interest Expense | 1.55 Million | 1.48 Million | 936 Thousand | 1.75 Million | 3.46 Million | 3.89 Million |
| Income Tax Expense | 2800.00 | 2800.00 | 2000.00 | -3.27 Million | -3.41 Million | -3.64 Million |
| Earnings before Tax | -58.97 Million | -66.04 Million | -53.16 Million | -38.51 Million | -37.93 Million | -33.74 Million |
| Net Income | -58.98 Million | -66.05 Million | -53.16 Million | -35.23 Million | -34.52 Million | -46.11 Million |
| Earnings Per Share Basic | -4.72 | -6.23 | -6.96 | -9.71 | -37.96 | -50.70 |
| Earnings Per Share Diluted | -4.72 | -6.23 | -6.96 | -9.71 | -37.96 | -50.70 |
| Weighted Average Shares Outstanding | 12.5 Million | 10.6 Million | 7.63 Million | 3.62 Million | 909.59 Thousand | 909.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 12.5 Million | 10.6 Million | 7.63 Million | 3.62 Million | 909.59 Thousand | 909.59 Thousand |
| Gross Margin | - | - | - | - | 1.00 | 0.99 |
| EBIT Margin | - | - | - | - | -2.66 | -7.25 |
| Profit Margin | - | - | - | - | -4.24 | -14.94 |
| EBITDA | -57.37 Million | -62.86 Million | -51.46 Million | -35.75 Million | -31.1 Million | -26.79 Million |
| Earnings Before Tax Margin | - | - | - | - | -4.46 | -8.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 28.67 Thousand | 28.19 Thousand | 28.19 Thousand | 44.18 Thousand | 11.21 Thousand | 11.19 Thousand |
| Gross Profit | -28.67 Thousand | -28.19 Thousand | -28.19 Thousand | -44.18 Thousand | -11.21 Thousand | -11.19 Thousand |
| Operating Expenses | 19.53 Million | 18.91 Million | 10.32 Million | 53.12 Million | 12.45 Million | 18.14 Million |
| Selling, General and Administrative Expenses | 8.33 Million | 5.4 Million | 5.79 Million | - | 7.51 Million | 7.04 Million |
| Research and Development Expenses | 11.2 Million | 13.5 Million | 4.52 Million | - | 4.94 Million | 11.1 Million |
| Other Expenses | 7.56 Million | -8.51 Million | -993 Thousand | -3.75 Million | -843 Thousand | -2.91 Million |
| Cost and Expenses | 19.56 Million | 18.93 Million | 10.32 Million | 53.12 Million | 12.45 Million | 18.14 Million |
| Operating Income | -19.56 Million | -18.93 Million | -10.32 Million | -53.12 Million | -12.45 Million | -18.14 Million |
| Interest Expense | - | 3084.03 Billion | -188.67 Billion | 1.55 Million | 2142.77 Billion | -395.23 Billion |
| Income Tax Expense | -2.00 | 2800.00 | -135.33 Thousand | 3000.00 | 2.79 Billion | -394.19 Thousand |
| Earnings before Tax | 44.4 Million | -114.28 Million | -11.17 Million | -58.98 Million | -12.99 Million | -20.67 Million |
| Net Income | 44.4 Million | -114.28 Million | -11.17 Million | -58.98 Million | -12.99 Million | -20.67 Million |
| Earnings Per Share Basic | 1.91 | -8.01 | -0.86 | - | -1.00 | -1.61 |
| Earnings Per Share Diluted | -0.88 | -8.01 | -0.86 | - | -1.00 | -1.61 |
| Weighted Average Shares Outstanding | 23.22 Million | 14.27 Million | 13.01 Million | 12.5 Million | 13.01 Million | 12.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.47 Million | 14.27 Million | 13.01 Million | 12.5 Million | 13.01 Million | 12.84 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -19.53 Million | -18.91 Million | -10.24 Million | - | -16.75 Million | -18.12 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
KIRLPNU
1737
9627
XNCR
BALKRISIND
PADI